| Heading: |
Neuroendocrine Cancer: Radiotherapy |
| Question ID: |
1791622 |
| UIN: |
43451 |
| House: |
Commons |
| Date tabled: |
2025-04-02 |
| Asking Member ID: |
4126 |
| Asking Member display name: |
Mary Glindon
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Mary Glindon
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of selective internal radiation therapy on the (a) survival outcomes and (b) quality of life for neuroendocrine tumour patients. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-04-08 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
No assessment has been made on the potential impact of selective internal radiation therapy (SIRT) on survival outcomes and quality of life for neuroendocrine tumour patients. However, the Department recognises the need to offer suitable treatment, includ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |